Accelerate to discover

Back to filter

Related topics

Internal radiation dosimetry of a 152Tb-labeled antibody in tumor-bearing mice

Bruker Biospin

Feb 20, 2020

MicroPET-based dosimetry of 152Tb is feasible, and the comparison with organ harvesting resulted in acceptable dose...

ONI Nanoimager - The world’s first desktop super-resolution microscope

ONI

Feb 18, 2020

The Nanoimager is the complete package in super-resolution microscopy, offering various modes of operation including...

Travel grant ALERT! Submit ESHG abstracts today

BioNano Genomics

Feb 13, 2020

Interested in sharing your Bionano Genomics data at ESHG 2020 in Berlin? Eager to share how you have utilized the...

AutoLV analysis software

VisualSonics FujiFilm

Feb 11, 2020

AutoLV analysis software is the latest addition to VisualSonics robust suite of measurement tools customized for...

Feb 21, 2020

CellPathfinder Software, High Content Analysis and powerful Deep Learning features

Yokogawa

Feb 7, 2020

The intuitive CellPathfinder Software guides the user throughout the process. It analyzes and digitizes complex...

COY - personalized hypoxic and anaerobic chambers since 1969

COY laboratory products

Jan 31, 2020

When your research requires consistent atmospheric control to maintain anoxia, hypoxia, normoxia, or hyperoxia, you can...

Metabolic MR Imaging of Obesity

Bruker Biospin

Jan 29, 2020

Obesity is now known to be much more than a cosmetic problem with its association with a wide plethora of diseases...

Feb 21, 2020

Micro-CT in 3D data integration and (Clinical) workflows for digital orthodontics

Bruker Biospin

Jan 29, 2020

Petra Julia Koch and Paul Zaslansky (Charité - Universitätsmedizin Berlin) will discuss the importance of 3D data in...

Show all topics (10)

Morphological and pharmacological in-vitro kinetic angiogenesis assays

Nov 16, 2016

The ADSC/ECFC model yields rapidly forming (<48h) endothelial cell‘cord’structures. In the NHDF/HUVEC slowly forming‘tube-like’structures appear which continue to develop and branch even after 10days in culture. High basal formation was observed in the ADSC/ECFC model, but not in the NHDF/HUVEC model. From immuno-cytochemistry, the ADSCs surrounding the cord network label for PDGFR-β and a-SMA, suggesting apericyte phenotype.The pharmacological effects of growth factors and different pathway inhibitors were largely comparable. Interestingly, established cords and tubes display marked resistance to Avastin (Bevacizumab) compared to developing networks. G-secretase inhibition partially reversed established tubes in ADSC/ECFCs and augmented late state branching in the NHDF/HUVEC model. We conclude that these 2 models exhibit strikingly different morphological, temporal and pharmacological profiles. The resistance of established vascular structures to disruption by Avastin (Bevazicumab) may represent a useful translational paradigm for addressing tumour resistance of anti-VEGF therapies.

Read more

Scientific paper
Application
Product news

Related technologies: Real-time, label free cell analysis

Get more info

Riccardo Pasculli

Head of application support

Riccardo

Pasculli

+420 731 127 717

Send Message

Brand profile

Sartorius

Essen BioScience (part of Sartorius), is a team of engineers and biologists with deep expertise in cell-based assays. We invent, manufacture, supply and support cell-based assay instrumentation, reagents and protocols.

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey